Industries and Services

Position: Home> Industries and Services> Health Finance Ecosystem

HEALTH FINANCE ECOSYSTEM

Health Finance Ecosystem

As the incubator of innovative business in health industry, the Health Finance Ecosystem adheres to the concept of serving startups and supporting innovation. With Baheal's commercialization platform as its core and supported by the innovation fund, we provide financial capital and industrial support in terms of resources, capital, marketing and promotion for innovative enterprises, construct a health finance industry cluster covering advanced technologies, products and services. We have made breakthroughs in smart healthcare, bio-diagnostics, high-end R&D and manufacturing, and third-party prescription flow platforms.

As the incubator of innovative business in health industry, the Health Finance Ecosystem adheres to the concept of serving startups and supporting innovation. With Baheal's commercialization platform as its core and supported by the innovation fund, we provide financial capital and industrial support in terms of resources, capital, marketing and promotion for innovative enterprises, construct a health finance industry cluster covering advanced technologies, products and services. We have made breakthroughs in smart healthcare, bio-diagnostics, high-end R&D and manufacturing, and third-party prescription flow platforms.

stq_internet

Baheal Zhongxin-healthcare capital,.Ltd

Baheal Zhongxin was co-founded in 2014 by Baheal Pharmaceutical Group, a number of veterans in the field of medicine and general health.Zhongxin Fund is positioned as an innovative business incubator for the health industry, focusing on building a professional, market-oriented and standardized open fund management platform, focusing on the pharmaceutical and general health sectors, and operating in accordance with the market-oriented investment management company.

Baheal Zhongxin was co-founded in 2014 by Baheal Pharmaceutical Group, a number of veterans in the field of medicine and general health.Zhongxin Fund is positioned as an innovative business incubator for the health industry, focusing on building a professional, market-oriented and standardized open fund management platform, focusing on the pharmaceutical and general health sectors, and operating in accordance with the market-oriented investment management company.

More

Baheal Intelligent Technology

Baheal Intelligent Technology is positioned to optimize medical scenarios based on smart medical technology. It is based on the medical data structured and AI algorithms technology platform as the foundation, to have good data and operation and the characteristics of medical institutions as the core, the industrialization of innovative product oriented, for the government, hospitals, pharmaceutical companies, pharmacies, doctors, patients, with more than the whole chain, the overall solution, optimize medical resources, improve medical service quality and efficiency of the platform of science and technology enterprise.

Baheal Intelligent Technology is positioned to optimize medical scenarios based on smart medical technology. It is based on the medical data structured and AI algorithms technology platform as the foundation, to have good data and operation and the characteristics of medical institutions as the core, the industrialization of innovative product oriented, for the government, hospitals, pharmaceutical companies, pharmacies, doctors, patients, with more than the whole chain, the overall solution, optimize medical resources, improve medical service quality and efficiency of the platform of science and technology enterprise.

More

Yifuzhen

The Yifuzhen third-party prescription circulation service platform takes patients as the core, and jointly builds with government, medical institutions, and prescription transfer participants such as drug retail enterprises and drug distribution companies to realize the interconnection of prescription information, medical insurance settlement information and retail drug consumption information of medical institutions. Interoperability and real-time sharing.Based on the regional standard prescription library, Easy Revisit provides the government with real-time and accurate prescription data supervision, providing patients with prescription information query, relying on the independent purchase of medicines, relying on the online re-examination, delivery of drugs, online physician communication and medication guidance The complete prescription service effectively solves the problems of "seeking medical treatment due to medicines" and improving the patient's medical purchase experience.Up to now, the platform has realized the implementation and implementation of 1 provincial-level project, 6 prefecture-level and city-level projects, as well as 300 hospital projects, covering nearly 100 million people.

The Yifuzhen third-party prescription circulation service platform takes patients as the core, and jointly builds with government, medical institutions, and prescription transfer participants such as drug retail enterprises and drug distribution companies to realize the interconnection of prescription information, medical insurance settlement information and retail drug consumption information of medical institutions. Interoperability and real-time sharing.Based on the regional standard prescription library, Easy Revisit provides the government with real-time and accurate prescription data supervision, providing patients with prescription information query, relying on the independent purchase of medicines, relying on the online re-examination, delivery of drugs, online physician communication and medication guidance The complete prescription service effectively solves the problems of "seeking medical treatment due to medicines" and improving the patient's medical purchase experience.Up to now, the platform has realized the implementation and implementation of 1 provincial-level project, 6 prefecture-level and city-level projects, as well as 300 hospital projects, covering nearly 100 million people.

More

Baheal Biodiagnostics

Based on independent innovation, Baheal Biodiagnostics uses immune and molecular diagnostic technologies, combined with artificial intelligence imaging and treatment plan recommendations, to help doctors achieve accurate clinical decisions such as early tumor screening, early diagnosis, standardized treatment, and prognostic evaluation. It can also provide patients with prevention, diagnosis, treatment and rehabilitation of the whole process of tumor diagnosis and treatment solutions.

Based on independent innovation, Baheal Biodiagnostics uses immune and molecular diagnostic technologies, combined with artificial intelligence imaging and treatment plan recommendations, to help doctors achieve accurate clinical decisions such as early tumor screening, early diagnosis, standardized treatment, and prognostic evaluation. It can also provide patients with prevention, diagnosis, treatment and rehabilitation of the whole process of tumor diagnosis and treatment solutions.

More

Qingdao Baheal Pharmaceutical Co., Ltd.,

Qingdao Baheal Pharmaceutical Co., Ltd., is a pharmaceutical enterprise jointly established by baheal pharmaceutical group. The company takes pharmaceutical technology innovation and GMP compliance as the core, and slow and controlled release technology drug research and development and production as its characteristics. Facing domestic, European and American overseas markets, the company is committed to building an international manufacturing platform for generic drugs, and has passed the us FDA prescription drug certification with zero defects, laying a solid foundation for the internationalization of pharmaceutical products.

Qingdao Baheal Pharmaceutical Co., Ltd., is a pharmaceutical enterprise jointly established by baheal pharmaceutical group. The company takes pharmaceutical technology innovation and GMP compliance as the core, and slow and controlled release technology drug research and development and production as its characteristics. Facing domestic, European and American overseas markets, the company is committed to building an international manufacturing platform for generic drugs, and has passed the us FDA prescription drug certification with zero defects, laying a solid foundation for the internationalization of pharmaceutical products.

More

Sundise

Sundise is a high-tech enterprise specializing in the modernization of traditional Chinese medicine.The company relies on the traditional Chinese medicine inheritance and innovation base of Shanghai University of Traditional Chinese Medicine, pharmaceutical manufacturing engineering technology, the birthplace of East China University of Science and Technology, and the sales and marketing network of Baheal Pharmaceutical.The company has developed into a strong body of production, education and research, with a complete industrial chain.

Sundise is a high-tech enterprise specializing in the modernization of traditional Chinese medicine.The company relies on the traditional Chinese medicine inheritance and innovation base of Shanghai University of Traditional Chinese Medicine, pharmaceutical manufacturing engineering technology, the birthplace of East China University of Science and Technology, and the sales and marketing network of Baheal Pharmaceutical.The company has developed into a strong body of production, education and research, with a complete industrial chain.

More

Medical Vedio

Medical Video implements the strategy of "Healthy China", and cooperates with the spirit of "Health Promotion for All" by the Department of Public Health of the Health Commission.It is guided by the Scientific Popularization Branch of the Chinese Medical Association, the Medical Popularization Branch of the Chinese Medical Doctors Association, and produced by the Health Science Popularization Research Center of the Chinese Academy of Medical Sciences. host.A large-scale medical science project implemented with the purpose of "let people know a little more about medical knowledge, and health is more guaranteed" to meet the public's demand for authority and professional medical knowledge and improve the level of public medical literacy.Medical Video hope that more patients can share the valuable experience and knowledge accumulated by medical experts for many years, and can help the people in need.

Medical Video implements the strategy of "Healthy China", and cooperates with the spirit of "Health Promotion for All" by the Department of Public Health of the Health Commission.It is guided by the Scientific Popularization Branch of the Chinese Medical Association, the Medical Popularization Branch of the Chinese Medical Doctors Association, and produced by the Health Science Popularization Research Center of the Chinese Academy of Medical Sciences. host.A large-scale medical science project implemented with the purpose of "let people know a little more about medical knowledge, and health is more guaranteed" to meet the public's demand for authority and professional medical knowledge and improve the level of public medical literacy.Medical Video hope that more patients can share the valuable experience and knowledge accumulated by medical experts for many years, and can help the people in need.

More

CH Biomedical, Inc.

CH Biomedical, Inc. is committed to leading the global breakthrough in ventricular assist devices (artificial heart) technology, so that ventricular assist devices can benefit a wider range of patients.The company has designed and completed the latest generation of artificial heart CH-VAD based on full magnetic levitation technology. It will soon complete clinical trials in China, and will soon complete pre-clinical studies for PMA approval for the US FDA, including animal trials.The company has become the only company capable of competing with Abbott, the world's strongest artificial heart company, and is expected to surpass the latter in this field.

CH Biomedical, Inc. is committed to leading the global breakthrough in ventricular assist devices (artificial heart) technology, so that ventricular assist devices can benefit a wider range of patients.The company has designed and completed the latest generation of artificial heart CH-VAD based on full magnetic levitation technology. It will soon complete clinical trials in China, and will soon complete pre-clinical studies for PMA approval for the US FDA, including animal trials.The company has become the only company capable of competing with Abbott, the world's strongest artificial heart company, and is expected to surpass the latter in this field.